| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 732205 | Null | 0.012942183459279 | 0.094194283 |
| NSC 733476 | Null | 0.012942183459279 | 0.016236086 |
| NSC 734949 | 4-[3-(3,4-dihydro-1H-isoquinolin-2-yl)prop-1-en-2-yl]-N-pyrazin-2-ylbenzamide | 0.012942183459279 | 0.042175304 |
| NSC 735472 | (2E,8S,9Z)-2,9,16-heptadecatrien-4,6-diyn-1,8-diol | 0.012942183459279 | 0.066742041 |
| NSC 740357 | Null | 0.012942183459279 | 0.19092247 |
| NSC 744023 | (11aS)-8-(3-{4-[(E)-3-(2-hydroxyphenyl)-3-oxo-1-propenyl]-2-methoxyphenoxy}propoxy)-7-methoxy-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-5-one | 0.012942183459279 | 0.25419923 |
| NSC 762346 | Null | 0.012942183459279 | 0.21529081 |
| NSC 762901 | trans-4-{4-[3-(4-chloro-3-trifluoromethyl-phenyl)-ureido]-cyclohexyloxy}-pyridine-2-carboxylic acid methylamide | 0.012942183459279 | -0.10870702 |
| NSC 294530 | Null | 0.0133012546828914 | 0.0050585386 |
| NSC 50273 | Pyridine, 3-[[4-[bis(2-chloroethyl)amino]-2-methylbenzylidene]amino]- | 0.0133012546828914 | 0.10168796 |